Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.

Liver stiffness measurement (LSM) using transient elastography (Fibroscan®) can identify individuals with potential underlying liver disease. We evaluated the prevalence of abnormal LSM values as assessed using LSM and its predictors in HIV-infected asymptomatic patients receiving combined antiretro...

Full description

Bibliographic Details
Main Authors: Sang Hoon Han, Seung Up Kim, Chang Oh Kim, Su Jin Jeong, Jun Yong Park, Jun Yong Choi, Do Young Kim, Sang Hoon Ahn, Young Goo Song, Kwang-Hyub Han, June Myung Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3536776?pdf=render
_version_ 1818947866500005888
author Sang Hoon Han
Seung Up Kim
Chang Oh Kim
Su Jin Jeong
Jun Yong Park
Jun Yong Choi
Do Young Kim
Sang Hoon Ahn
Young Goo Song
Kwang-Hyub Han
June Myung Kim
author_facet Sang Hoon Han
Seung Up Kim
Chang Oh Kim
Su Jin Jeong
Jun Yong Park
Jun Yong Choi
Do Young Kim
Sang Hoon Ahn
Young Goo Song
Kwang-Hyub Han
June Myung Kim
author_sort Sang Hoon Han
collection DOAJ
description Liver stiffness measurement (LSM) using transient elastography (Fibroscan®) can identify individuals with potential underlying liver disease. We evaluated the prevalence of abnormal LSM values as assessed using LSM and its predictors in HIV-infected asymptomatic patients receiving combined antiretroviral treatment (cART) without HBV/HCV coinfection.We prospectively recruited 93 patients who had consistently been undergoing cART for more than 12 months at Severance Hospital in Seoul, Republic of Korea, from June to December 2010. LSM values >5.3 kPa were defined as abnormal.Thirty-nine (41.9%) had abnormal LSM values. On multivariate correlation analysis, the cumulative duration of boosted and unboosted protease inhibitors (PIs) were the independent factors which showed a negative and positive correlation to LSM values, respectively (β = -0.234, P = 0.023 and β = 0.430, P<0.001). In multivariate logistic regression analysis, the cumulative exposure duration of boosted-PIs and γ-glutamyltranspeptidase levels were selected as the independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively (odds ratio [OR], 0.941; 95% confidence interval [CI], 0.889-0.997; P = 0.039 and OR, 1.032; 95% CI, 1.004-1.060; P = 0.023).The high percentage of HIV-infected asymptomatic patients receiving cART without HBV/HCV coinfection had abnormal LSM values. The cumulative exposure duration of boosted-PIs and γ-GT level were independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively.
first_indexed 2024-12-20T08:37:43Z
format Article
id doaj.art-1f8bcafb84bc42c2b62f380ce533b45f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T08:37:43Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1f8bcafb84bc42c2b62f380ce533b45f2022-12-21T19:46:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0181e5272010.1371/journal.pone.0052720Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.Sang Hoon HanSeung Up KimChang Oh KimSu Jin JeongJun Yong ParkJun Yong ChoiDo Young KimSang Hoon AhnYoung Goo SongKwang-Hyub HanJune Myung KimLiver stiffness measurement (LSM) using transient elastography (Fibroscan®) can identify individuals with potential underlying liver disease. We evaluated the prevalence of abnormal LSM values as assessed using LSM and its predictors in HIV-infected asymptomatic patients receiving combined antiretroviral treatment (cART) without HBV/HCV coinfection.We prospectively recruited 93 patients who had consistently been undergoing cART for more than 12 months at Severance Hospital in Seoul, Republic of Korea, from June to December 2010. LSM values >5.3 kPa were defined as abnormal.Thirty-nine (41.9%) had abnormal LSM values. On multivariate correlation analysis, the cumulative duration of boosted and unboosted protease inhibitors (PIs) were the independent factors which showed a negative and positive correlation to LSM values, respectively (β = -0.234, P = 0.023 and β = 0.430, P<0.001). In multivariate logistic regression analysis, the cumulative exposure duration of boosted-PIs and γ-glutamyltranspeptidase levels were selected as the independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively (odds ratio [OR], 0.941; 95% confidence interval [CI], 0.889-0.997; P = 0.039 and OR, 1.032; 95% CI, 1.004-1.060; P = 0.023).The high percentage of HIV-infected asymptomatic patients receiving cART without HBV/HCV coinfection had abnormal LSM values. The cumulative exposure duration of boosted-PIs and γ-GT level were independent predictors which showed a negative and positive correlation with abnormal LSM values, respectively.http://europepmc.org/articles/PMC3536776?pdf=render
spellingShingle Sang Hoon Han
Seung Up Kim
Chang Oh Kim
Su Jin Jeong
Jun Yong Park
Jun Yong Choi
Do Young Kim
Sang Hoon Ahn
Young Goo Song
Kwang-Hyub Han
June Myung Kim
Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.
PLoS ONE
title Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.
title_full Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.
title_fullStr Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.
title_full_unstemmed Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.
title_short Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.
title_sort abnormal liver stiffness assessed using transient elastography fibroscan r in hiv infected patients without hbv hcv coinfection receiving combined antiretroviral treatment
url http://europepmc.org/articles/PMC3536776?pdf=render
work_keys_str_mv AT sanghoonhan abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT seungupkim abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT changohkim abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT sujinjeong abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT junyongpark abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT junyongchoi abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT doyoungkim abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT sanghoonahn abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT younggoosong abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT kwanghyubhan abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment
AT junemyungkim abnormalliverstiffnessassessedusingtransientelastographyfibroscaninhivinfectedpatientswithouthbvhcvcoinfectionreceivingcombinedantiretroviraltreatment